Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8247351 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusions: COX-2 overexpression and reduced apoptosis in PTB can predict poor response of rectal cancer to RCT. As COX-2 inhibitors are commercially available, their administration to patients who overexpress COX-2 warrants assessment in clinical trials in an attempt to increase overall response rates.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Fraser M. M.R.C.S.I., John V. (F.R.C.S.I.), Elaine W. (F.R.C.S.I., F.R.C.P.I.), Paul M.D., James O. M.R.C.S.I., Donal M.D., Eoin F. M.D., Richard B. (F.R.C.S.I.), M. John (F.R.C.P.I.),